Publication | Open Access
An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer
148
Citations
19
References
2008
Year
Our 72-gene signature is closely associated with recurrence-free and overall survival in early-stage NSCLC patients and may become a tool for patient selection for adjuvant therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1